Part II: Clinical Challenges and Renal Considerations in Managing Gout
Release Date: April 2012
Expiration Date: April 2013
Estimated time to complete the educational activity: 1 hour
This activity is jointly sponsored by Medical Education Resources and Haymarket Medical Education and is supported by an educational grant from Savient Pharmaceuticals.
Statement of Need: Clinicians today face an increasing number of patients with gout. Nephrologists in particular must contend with complex cases in patients with varying degrees and stages of renal dysfunction in addition to other comorbidities and individual characteristics that affect treatment decisions and, ultimately, treatment success. As gout occurs in tandem with renal disorders, nephrologists must be able to appropriately identify and treat these patients.
Target Audience: This activity has been designed to meet the educational needs of nephrologists and other clinicians involved in the treatment of patients with gout.
Educational Objectives: After completing the activity, the participant should be better able to:
- Describe how renal function affects the management of gout.
- Evaluate current and emerging options for urate-lowering therapy with regard to their benefits and limitations in patients with varying degrees of renal impairment.
- Discuss ways to motivate patient adherence to a long-term treatment plan that incorporates lifestyle considerations and pharmacotherapy
Accreditation Statement:This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Medical Education Resources (MER) and Haymarket Medical Education. MER is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation: Medical Education Resources designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest: Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure all scientific research referred to, reported, or used in a CME activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality CME activities that promote improvements or quality in health care and not a commercial interest.
|Name of Faculty||Reported Financial Relationship|
|James W. Lohr, MD||No financial relationships to disclose|
|Anthony J. Bleyer, MD (Faculty Chair)||Consultant: Takeda Pharmaceuticals, Savient Pharmaceuticals|
The content managers, Marjorie Hale, Jill Rovitzky Black, Susan Basilico, Jody A. Charnow, and Marina Galanakis of Haymarket Medical Education, and Victoria Smith, MD, of Medical Education Resources, have disclosed that they have no relevant financial relationships or conflicts of interest.
Method of Participation: There are no fees for participating in and receiving CME credit for this activity. During the period April 2012 through April 2013, participants must: 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the posttest and submit it online. Physicians may register at http://www.mycme.com/pages/cmelogin.aspx?returl=http://www.mycme.com/clinical-challenges-and-renal-considerations-in-managing-gout-part-ii/material/953/2578/&pagetypeid=12, and 4) complete the evaluation form online.
A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed post-test with a score of 70% or better.